Drew Sycoff - 01 Jul 2024 Form 4 Insider Report for GlucoTrack, Inc. (GCTK)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: GCTK
Reported as of: 01 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jul 2024, 17:39:00 UTC
Prior SEC filing: 24 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Andrew Sycoff, By Kathryn Simons through Power of Attorney

Key filing fact

Drew Sycoff filed Form 4 for GlucoTrack, Inc. (GCTK) on 03 Jul 2024.

Key facts

This page summarizes Drew Sycoff's Form 4 filing for GlucoTrack, Inc. (GCTK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jul 2024, 17:39.

Change

Previous filing in this sequence was filed on 24 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GCTK transaction Derivative

Warrants to Purchase Common Stock

Purchase

Transaction value
Shares: +138,000
Change %
Price
Shares after: 138,000
Date: 01 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 138,000
Exercise price: $4.95
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 138,000 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") for an aggregate purchase price of $46,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance.